Send us Feedback

Enzon Pharmaceuticals (ENZN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ENZN » Topics » Preferred Stock

These excerpts taken from the ENZN 10-K filed Mar 9, 2009.

Preferred Stock

The Company has authorized 3,000,000 shares of preferred stock in one or more series of which 600,000 are designated as Series B in connection with the Rights Plan.

F-19

ENZON PHARMACEUTICALS, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)

Preferred Stock

The Company has authorized 3,000,000 shares of preferred stock in one or more series of which 600,000 are designated as Series B in connection with the Rights Plan.

F-19

ENZON PHARMACEUTICALS, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)

Preferred Stock


The Company has authorized 3,000,000 shares of preferred stock in one or more series of which 600,000 are designated as Series B in connection with the Rights Plan.


F-19





ENZON PHARMACEUTICALS, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)


Preferred Stock


The Company has authorized 3,000,000 shares of preferred stock in one or more series of which 600,000 are designated as Series B in connection with the Rights Plan.


F-19





ENZON PHARMACEUTICALS, INC. AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)


This excerpt taken from the ENZN 10-K filed Mar 2, 2007.
Preferred Stock
 
The Company has authorized 3,000,000 shares of preferred stock in one or more series of which 600,000 are designated as Series B in connection with the Shareholder Rights Plan.
 

EXCERPTS ON THIS PAGE:

10-K (4 sections)
Mar 9, 2009
10-K
Mar 2, 2007

RELATED TOPICS for ENZN:

"Preferred Stock" elsewhere:

Affymax (AFFY)
Alnylam Pharmaceuticals (ALNY)
Cerus (CERS)
Clinical Data (CLDA)
Dyax (DYAX)
Biota Pharmaceuticals, Inc. (NABI)
ARCA biopharma, Inc. (NUVO)
Pharmacopeia Drug Discovery (PCOP)
Questcor Pharmaceuticals (QSC)
Trubion Pharmaceuticals (TRBN)
Tercica (TRCA)
SYNAGEVA BIOPHARMA CORP (TRMS)
Gilead Sciences (GILD)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki